AFT Pharmaceuticals (ASX:AFP) Operating Cash Flow per Share : A$0.12 (TTM As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is AFT Pharmaceuticals Operating Cash Flow per Share?

AFT Pharmaceuticals's operating cash flow per share for the six months ended in Sep. 2023 was A$0.07. AFT Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was A$0.12.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of AFT Pharmaceuticals was -1.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for AFT Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

ASX:AFP' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -10.1 Med: 60.3 Max: 130.7
Current: -10.1

During the past 8 years, AFT Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 130.70% per year. The lowest was -10.10% per year. And the median was 60.30% per year.

ASX:AFP's 3-Year OCF Growth Rate is ranked worse than
74.1% of 807 companies
in the Drug Manufacturers industry
Industry Median: 8.2 vs ASX:AFP: -10.10

AFT Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for AFT Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Operating Cash Flow per Share Chart

AFT Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.01

0.15

0.01

0.13

0.10

AFT Pharmaceuticals Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Operating Cash Flow per Share	Get a 7-Day Free Trial											0.06	0.07	0.05	0.05	0.07

Competitive Comparison of AFT Pharmaceuticals's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AFT Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

AFT Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

AFT Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	10.813	/	104.849
	=	0.10

AFT Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	6.892	/	104.866
	=	0.07

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.12

AFT Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals (ASX:AFP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

AFT:New Zealand

Address

129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622

Website

https://www.aftpharm.com

AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (ASX:AFP) Headlines

No Headlines